CAS RN: 16094-31-8
5-(1,1-dimethylethyl)salicylic acid
Product Availability
Choose a grade to view its available package options.
5 package records4 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20260309 |
100mg |
In stock |
| Inquiry |
| Batchno.20250418 |
100mg / 250mg / 1g / 5g |
Out of stock |
5-7 business days | Inquiry |
| Batchno.20250714 |
1g |
In stock |
| Inquiry |
| Batchno.20260529 |
250mg |
In stock |
| Inquiry |
| Batchno.20250302 |
5g |
In stock |
| Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 5g, 0.1g, 0.25g
- Available purity: >97%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 16094-31-8
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
>97% |
5
In Stock
|
Beijing |
Inquiry |
| 5g |
>97% |
4
In Stock
|
Hong Kong |
Inquiry |
| 0.1g |
>97% |
2
In Stock
|
Beijing |
Inquiry |
| 0.25g |
>97% |
2
In Stock
|
Hong Kong |
Inquiry |
16094-31-8 / 5-tert-butyl-2-hydroxybenzoic acid
Standard CAS: 16094-31-8
Multi CAS: No
Basic Information
CAS
16094-31-8
Multi CAS
No
Molecular Formula
C11H14O3
Molecular Weight
194.230000
Exact Mass
194.094294
SMILES
CC(C)(C)C1=CC(=C(C=C1)O)C(=O)O
InChI
InChI=1S/C11H14O3/c1-11(2,3)7-4-5-9(12)8(6-7)10(13)14/h4-6,12H,1-3H3,(H,13,14)
InChIKey
XAICWTLLSRXZPB-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
14
Aromatic heavy atom count
6
Fraction Csp3
0.36
Rotatable bonds
1
H-bond acceptors
2
H-bond donors
2
Molar refractivity
53.77
TPSA
57.53
LogP / Solubility
WLOGP
2.39
MLOGP
2.1
XLogP3
4.1
Consensus LogP
2.86
Log S (ESOL)
-2.8
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.88
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-3.02
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.21
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5